Virginia's governor has vetoed a significant piece of legislation intended to create an advisory panel focused on reducing prescription drug costs.
This decision, made on May 19, 2026, has drawn attention as it could affect potential savings for residents in the state.
The veto reflects ongoing discussions and debates surrounding healthcare costs and the accessibility of affordable medications.